Diagnostic test for ovarian cancer

Thursday, 01 January, 2009 | Supplied by: Manalto Inc

The OvPlex Panel is an early detection test for ovarian cancer, developed by HealthLinx in collaboration with ARL Pathology.

The test works by measuring five different biomarkers (proteins) in blood that are associated with ovarian cancer. It then builds a diagnostic based on that information rather than relying on a single marker for the disease.

Results are available within a fortnight.

Online: www.healthlinx.com.au
Phone: 03 9208 4200

Cayman Chemical Cellular Metabolism Screening Library

Cayman Chemical's Cellular Metabolism Screening Library consists of two plates and contains...

Navinci Diagnostics NaveniFlex Cell Red proximity ligation assay kit

Optimised for cell samples, the kit enables fluorescence visualisation of protein–protein...

Lonza TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium

The products provide researchers and manufacturers with high-performance, scalable and...

Content from other channels on our network

Blending operations boosted using rotary batch mixer

CCEP inspires young workers to create influential change

Helen Strachan appointed Chair of Australian Grape & Wine

Boosting plant-based protein manufacturing in regional NSW

High-protein concepts on show in Paris

Concrete repair key to sustainability

Signposting the way to a regenerative economy

Pledges favour land-based carbon removal over emission cuts

Epson opens smart factory with Citizen Wolf

MSCI report shows rising climate risks

Engineers Australia CEO calls for action to address engineering shortages

Victorian Government funding safer manufacturing workplaces

Major Korean steelmaker joins HILT CRC

WA Government wants its projects to be built with local green steel

ASC selects Siemens software for Collins Class submarines